Teva Pharmaceuticals USA recalls Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when
Recalled September 16, 2020 · FDA recall D-1566-2020 · Teva Pharmaceuticals USA
Hazard
Sub-Potent Drug: Out of specification test results for potency (below specification). · FDA Class II
Units
38,487 bottles
Sold at
Nationwide in the U.S. and Puerto Rico.
Description
Sub-Potent Drug: Out of specification test results for potency (below specification).
Product
Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4177-73.
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →